A Retrospective Study of Definitive Radiotherapy in Locally Advanced Carcinoma of Uterine Cervix Treated Initially with Hypofractionation: A G.C.R.I. Experience
Journal Title: GUJARAT CANCER SOCIETY RESEARCH JOURNAL - Year 2018, Vol 20, Issue 1
Abstract
Locally advanced carcinoma cervix represents a heterogeneous group of patients. Those considered unsuitable for curative treatment at the time of presentation are generally treated with hypofractionated radiotherapy. This study evaluates locoregional outcome, early and late toxicities of bladder, rectum and vagina in locally advanced carcinoma cervix patients treated with initial short course of palliative hypofractionated radiotherapy and subsequently followed by curative radiotherapy. Between 2013 and 2016, a total of 254 patients of locally advanced cervical carcinoma were initially treated to a dose of 30Gy in 10 fractions over 2 weeks. Fifty two out of 254 patients (20.5%) were identified who were subsequently treated with curative radiotherapy after being initially treated with palliative hypo-fractionated radiotherapy. Forty three of 52 patients (82.7%) were suitable for complete course of pelvic irradiation. Out of 43, 28 patients received brachytherapy boost and 15 patients received external beam radiotherapy boost. With a median follow-up of 19 months, 19 patients out of 40 (47.5%) had complete response, 10 (25%) had subjective symptomatic response initially and 11 (27.5%) had progressive disease. Patients receiving brachytherapy had disease free survival (15 months vs. 19 months; p>0.05) as compared to those received pelvic boost by external radiotherapy. In our study, 20.5% patients of locally advanced cervical carcinoma patients treated with initial short course hypofractionated palliative external beam radiotherapy became eligible for curative radiotherapy. These patients show a reasonably good survival and acceptable delayed toxicities and use of brachytherapy boost in selected subset of patients is encouraged. The data of this study correlates well with studies of similar nature done in the past.
Authors and Affiliations
Jagruti Koladiya, Ankita Parikh, Mridul Anand, Prashant Patel, Saheli Saha, Prerak Agrawal
Keywords
Related Articles
- EP ID EP474076
- DOI -
- Views 37
- Downloads 0
Case Presentations for Morbidity, Mortality at Clinical Meetings
Case Presentations for Morbidity, Mortality at Clinical Meetings
Unilateral Proptosis: An Unusual Presentation of Prostate Cancer
Adenocarcinoma of prostate typically involves axial skeleton and has been infrequently reported in unusual sites like orbit. Prostatic carcinoma accounts for 8.3% of orbital metastasis and is more likely to present prior...
Summaries of Published Articles
Summaries of Published Articles
Relevance of Serum Interleukin-1α and Interleukin-1β in Thyroid Diseases
It has been hypothesized that cytokines which play major role as inflammatory mediators might serve as triggers of chronic inflammation and increase the risk of developing thyroid cancer. Studies have shown that Interleu...
Significance of Variable Number Tandem Repeats (VNTR) Polymorphism of Thymidylate Synthase Gene in Patients with Colorectal Cancer: A Preliminary Study
5-fluorouracil (5-FU) is the most frequently used chemotherapeutic agent in the treatment of colorectal cancer (CRC) both in adjuvant and in palliative therapy. This drug mainly acts by inhibiting the activity of its tar...